+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Artificial Pancreas Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • January 2022
  • Region: Global
  • TechNavio
  • ID: 5546085
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the artificial pancreas market and it is poised to grow by $ 450.95 mn during 2022-2026, progressing at a CAGR of 19.15% during the forecast period. The report on the artificial pancreas market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and favorable regulations and guidelines.

The artificial pancreas market analysis includes the type segment and geographic landscape.

The artificial pancreas market is segmented as below:


By Type

  • Threshold suspend device
  • Non-threshold suspend device
  • Control to range system
  • Control to target system

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising geriatric population as one of the prime reasons driving the artificial pancreas market growth during the next few years.

The report on artificial pancreas market covers the following areas:

  • Artificial pancreas market sizing
  • Artificial pancreas market forecast
  • Artificial pancreas market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial pancreas market vendors that include Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc. Also, the artificial pancreas market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2021
  • Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Threshold suspend device - Market size and forecast 2021-2026
  • Non-threshold suspend device - Market size and forecast 2021-2026
  • Control to range system - Market size and forecast 2021-2026
  • Control to target system - Market size and forecast 2021-2026
  • Market opportunity by Type

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2021-2026
  • Europe - Market size and forecast 2021-2026
  • Asia - Market size and forecast 2021-2026
  • ROW - Market size and forecast 2021-2026
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Admetsys Corp.
  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Defymed SAS
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corp.
  • Medtech Life Pvt. Ltd.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2021 - 2026 ($ million)
  • Global market: Year-over-year growth 2021 - 2026 (%)
  • Five forces analysis 2021 & 2026
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2021
  • Type - Market share 2021-2026 (%)
  • Comparison by Type
  • Threshold suspend device - Market size and forecast 2021-2026 ($ million)
  • Threshold suspend device - Year-over-year growth 2021-2026 (%)
  • Non-threshold suspend device - Market size and forecast 2021-2026 ($ million)
  • Non-threshold suspend device - Year-over-year growth 2021-2026 (%)
  • Control to range system - Market size and forecast 2021-2026 ($ million)
  • Control to range system - Year-over-year growth 2021-2026 (%)
  • Control to target system - Market size and forecast 2021-2026 ($ million)
  • Control to target system - Year-over-year growth 2021-2026 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share By Geographical Landscape 2021-2026 (%)
  • Geographic comparison
  • North America - Market size and forecast 2021-2026 ($ million)
  • North America - Year-over-year growth 2021-2026 (%)
  • Europe - Market size and forecast 2021-2026 ($ million)
  • Europe - Year-over-year growth 2021-2026 (%)
  • Asia - Market size and forecast 2021-2026 ($ million)
  • Asia - Year-over-year growth 2021-2026 (%)
  • ROW - Market size and forecast 2021-2026 ($ million)
  • ROW - Year-over-year growth 2021-2026 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Admetsys Corp. - Overview
  • Admetsys Corp. - Product and service
  • Admetsys Corp. - Key offerings
  • Admetsys Corp. - Key customers
  • Admetsys Corp. - Segment focus
  • Beta Bionics Inc. - Overview
  • Beta Bionics Inc. - Business segments
  • Beta Bionics Inc. - Key offerings
  • Beta Bionics Inc. - Key customers
  • Beta Bionics Inc. - Segment focus
  • Bigfoot Biomedical Inc. - Overview
  • Bigfoot Biomedical Inc. - Product and service
  • Bigfoot Biomedical Inc. - Key offerings
  • Bigfoot Biomedical Inc. - Key customers
  • Bigfoot Biomedical Inc. - Segment focus
  • Defymed SAS - Overview
  • Defymed SAS - Product and service
  • Defymed SAS - Key offerings
  • Defymed SAS - Key customers
  • Defymed SAS - Segment focus
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Business segments
  • Dexcom Inc. - Key offerings
  • Dexcom Inc. - Key customers
  • Dexcom Inc. - Segment focus
  • Inreda Diabetic B.V. - Overview
  • Inreda Diabetic B.V. - Product and service
  • Inreda Diabetic B.V. - Key offerings
  • Inreda Diabetic B.V. - Key customers
  • Inreda Diabetic B.V. - Segment focus
  • Insulet Corp. - Overview
  • Insulet Corp. - Business segments
  • Insulet Corp. - Key offerings
  • Insulet Corp. - Key customers
  • Insulet Corp. - Segment focus
  • Medtech Life Pvt. Ltd. - Overview
  • Medtech Life Pvt. Ltd. - Product and service
  • Medtech Life Pvt. Ltd. - Key offerings
  • Medtech Life Pvt. Ltd. - Key customers
  • Medtech Life Pvt. Ltd. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • Tandem Diabetes Care Inc. - Overview
  • Tandem Diabetes Care Inc. - Business segments
  • Tandem Diabetes Care Inc. - Key offerings
  • Tandem Diabetes Care Inc. - Key customers
  • Tandem Diabetes Care Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global artificial pancreas market: Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising geriatric population.`

According to the report, one of the major drivers for this market is the rising global burden of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Admetsys Corp.
  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Defymed SAS
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corp.
  • Medtech Life Pvt. Ltd.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.